Hjem › Fedme › Texas › Corpus Christi
Kliniske studier for Fedme i Corpus Christi, TX
6 studier for Fedme søker deltakere på steder i og rundt Corpus Christi (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
RekruttererFase 3
- Osvaldo A. Brusco MD, Corpus Christi
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
RekruttererFase 3
- Driscoll Children's Hospital, Corpus Christi
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
RekruttererFase 3
- Private Practice - Dr. Osvaldo A. Brusco, Corpus Christi
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
RekruttererFase 3
- South Texas Clinical Research, Corpus Christi
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
RekruttererFase 3
- Osvaldo A Brusco MD PA, Corpus Christi
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
RekruttererFase 3
- South Texas Clinical Research, Corpus Christi
Fedme-studier i andre byer
- Houston, TX43 studier
- Chicago, IL41 studier
- New York City, NY40 studier
- San Antonio, TX40 studier
- Washington, DC33 studier
- Orlando, FL31 studier
- Dallas, TX30 studier
- Boston, MA28 studier
- Las Vegas, NV27 studier
- Miami, FL27 studier
- Baltimore, MD25 studier
- Jacksonville, FL25 studier
Andre studier i Corpus Christi
- Overvekt5 studier
- Burkitts lymfom4 studier
- Type 2-diabetes4 studier
- Steatotisk leversykdom3 studier
- Akut bifenoypisk leukemi3 studier
- Akut myelogen leukemi3 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.